{"filing":{"accession_number":"0001294133-26-000032","cik":"0001294133","ticker":"INGN","company_name":"Inogen Inc","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"ingn-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1294133/000129413326000032/ingn-20260806.htm"},"events":[{"id":25699,"run_id":23322,"accession_number":"0001294133-26-000032","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Inogen, Inc. (the 'Company') issued a press release reporting its financial results for the second quarter ended June 30, 2026,\" with the press release furnished as Exhibit 99.1. The exhibit contains comprehensive quarterly financial results including revenue ($95.1M), net loss ($3.9M), adjusted EBITDA ($2.4M), and updated full-year guidance, along with operational highlights and management commentary—all hallmarks of a standard earnings release.","company_name":"Inogen Inc","ticker":"INGN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26596,"accession_number":"0001294133-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Inogen, Inc. (the 'Company') issued a press release reporting its financial results for the second quarter ended June 30, 2026,\" with the press release furnished as Exhibit 99.1. The exhibit contains comprehensive quarterly financial results including revenue ($95.1M), net loss ($3.9M), adjusted EBITDA ($2.4M), and updated full-year guidance, along with operational highlights and management commentary—all hallmarks of a standard earnings release.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:23:42.854768+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26596,"accession_number":"0001294133-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Inogen, Inc. (the 'Company') issued a press release reporting its financial results for the second quarter ended June 30, 2026,\" with the press release furnished as Exhibit 99.1. The exhibit contains comprehensive quarterly financial results including revenue ($95.1M), net loss ($3.9M), adjusted EBITDA ($2.4M), and updated full-year guidance, along with operational highlights and management commentary—all hallmarks of a standard earnings release.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:23:42.854768+00:00","company_name":"Inogen Inc","ticker":"INGN","filing_date":"2026-08-06"}]}